To prevent rejection and reduce toxicity, transplant patient results need to stay within a specific therapeutic range-and accurate, sensitive monitoring is crucial. The functional sensitivity of each assay meets this need and supports the current trend towards low immunosuppressive dosing regimens.
For in vitro diagnostic use.
Our transplant assays help clinicians make decisions regarding patient treatment to avoid side effects and induced nephrotoxicity, prevent organ rejection and monitor noncompliance. Our transplant assays are designed to quickly reflect the slightest shift in a patient’s test results. This helps the clinician make decisions regarding treatment protocols and aids in the management of liver and kidney allograph patients.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.